Therapeutics
Lyophilisation
Key to Overcoming Stability Hurdles for Complex Therapeutics
The pharmaceutical landscape is rapidly evolving driven by an influx of advanced treatments such as biologics
Genomic Medicine Keeps Innovating and Manufacturing Needs to Keep Pace
Genomic medicine the therapeutic use of cells and genetic materials is at the center of a medical revolution
c-MET Receptor Tyrosine Kinase: A Potential Biomarker for Cancer Therapeutics
CMET is a tyrosine kinase receptor in the MET family Normally it is expressed on the surfaces of several epithelial cells HGFSF is a common ligand of cMET receptors Cooper et al were the first to identify the MET oncogene in
